Nehmen Sie noch heute Kontakt mit G&L Scientific auf!

London   |   Belfast   |   Marlow
E: hello@gandlscientific.com
Warren, NJ   |   Boston, MA   |   San Diego, CA   |   Los Angeles, CA  |  Boca Raton, FL
E: hello@gandlscientific.com

Medical suppliers urged to ‘act now’ ahead of new Brexit border controls

24/11/20

The UK’s Department of Health and Social Care has written to medicine and medical product companies warning of potential supply chain disruption if they fail to prepare for new border controls at the end of the Brexit transition period.

Informa Pharma Intelligence’s ‘Pink Sheet’ repository reports the letter urges companies to ‘act now’ and prepare for the new rules and regulations which will come into force on 1 January 2021.

Written by Steve Oldfield, Chief Commercial Officer at the Department of Health and Social Care, the letter states: “you now have less than two months left so it is really important that you act now.”

Oldfield continues: “we must now step up preparations for a scenario where a negotiated outcome with the EU is not reached.”

However, the letter focuses almost entirely on preparing for the customs and border processes that will come into effect in January regardless of the outcome of the negotiations and makes no reference to any specific impacts of a “no-deal” scenario that companies might need to prepare for.

Oldfield also points out that an FTA “would not remove any of the requirements to act now to prepare for new customs and border processes.”

In a bid to mitigate the potential new border challenges, the DHSC has issued questionnaires and data requests to suppliers.

The UK is also planning to introduce phased border controls on its side of the Channel. However, suppliers are being reminded that they must prepare now for the changes and ensure they have the correct paperwork completed to avoid any delays when entering the EU from the UK after 1 January 2021.

The full article can be found here

Back to news

G&L SCIENTIFIC BETEILIGUNGEN